Centrexion therapeutics corporation

Major-Pharmaceuticals

CNTX


Executive/
Director

Price

  • Last Close
  • $ 0.83
    $ -0.17 -16.58 %
    Dec 9, 2022
  • 52-Week High/Low
  • $0 - $0
  • YTD
  • 0%

  • Trading Volume
  • 467,600
  • Market Cap Full
  • $ 13.3M
  • Shares Outstanding
  • 16M
    Nov 6, 2023
2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Q1 - - - - - - - -18.1% - -
Q2 - - - - - - - -2.8% - -
Q3 - - - - - - - -47.6% - -
Q4 - - - - - - -46.8% -25.2% - -
J F M A M J J A S O N D
2024 - - - - - - - - - - - -
2023 - - - - - - - - - - - -
    2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
    0%0%0%0%0%0%0%0%-69%0%0%

Earnings

2015 2016 2017 2018 2019 2020 2021 2022 2023
Q1 - - - - - - -2.55 -0.22 -0.40
Q2 - - - - - - -14.18 -0.25 -0.31
Q3 - - - - - - -4 -0.24 -0.37
Q4 - - - - - - 17.04 -0.22 -
A 0 0 0 0 0 -4 -3.7 -0.9 -1.08

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2021 2022 2023
Mar - 16 16
Jun - 16 16
Sep - 16 16
Dec 11 16 16

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover - - - - -
Total Asset Turnover - - - - -
Fixed Asset Turnover - - - - -
Leverage
Debt Ratio - - - - -
Debt – Equity Ratio - - - - -
Interest Coverage - 11 0.3 - -
Equity multiplier - - - - -